A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers

Completed · Phase 1

Conditions studied: Acne Vulgaris

In brief

A Phase I, Single-Center, Open-Label, Randomized, Parallel Group, 3 Day Study Evaluating the Safety and Cutaneous Tolerability of NVN1000 Topical Gel in Healthy Volunteers

Key facts

Study ID

NCT01755247

Run by

Novan, Inc.

People needed

15

Starts

2012-11-01

Expected to finish

2012-12-01

Last updated by the study team

2019-09-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy Male and Females > 18 years of age
• High degree of fluorescence of facial skin under Wood's lamp

You may not qualify if…

• Acute or chronic skin disorders
• Topical or systemic antibiotics within 4 weeks of study enrollment
• Use of medication that increases risk of methemoglobinemia or influences P. acnes counts
• Subjects with medical illnesses, anemia, elevated methemoglobin
• Women who are pregnant, nursing or planning a pregnancy

Where it is running

• KGL, Inc — Broomall, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.